A new study finds that obesity significantly reduces the effectiveness of urate-lowering therapy in male gout patients, with ...

for about 3 to 6 months after the beginning of that therapy it actually may be more common to have more gout attacks... which are actually physical uric acid precipitants that develop around ...

One study published in the journal Arthritis Research & Therapy, found that earlier menopause and a shorter reproductive span ...

Obesity significantly reduced the effectiveness of febuxostat-based urate-lowering therapy among men with gout, with those with obesity showing lower target achievement rates and more flares than ...

Time to crystal clearance relates to disease duration and to the serum uric acid level achieved with therapy ... poor renal function or tophaceous gout. The previous paragraphs described certain ...

SGLT2 inhibitors may help reduce the risk of nephrolithiasis in patients with type 2 diabetes, including those with co-existing gout. Recent large-scale studies support that sodium-glucose ...